1.
Transfusion
; 61(9): 2768-2771, 2021 09.
Article
in English
| MEDLINE | ID: covidwho-1416418
Subject(s)
Blood Banks , Blood Donors , Blood Donors/supply & distribution , Blood Safety , Blood Transfusion , Humans , United States
2.
J Clin Apher
; 36(3): 483-491, 2021 Jun.
Article
in English
| MEDLINE | ID: covidwho-1082675
ABSTRACT
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to a major pandemic. While vaccine development moves forward, optimal treatment continues to be explored. Efforts include an ever-expanding number of clinical trials along with newly proposed experimental and off-label investigational therapies; one of which is therapeutic plasma exchange (TPE). There have been a number of publications on TPE use as adjunctive therapy for coronavirus disease 2019 (COVID-19), but no prospective randomized controlled trials (RCTs) have been completed. This article critically appraises the current available evidence on TPE as a treatment modality for SARS-CoV-2 infection.